Breaks Categories: News

WednesdayMar 18, 2026 9:00 am

NetworkNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Breakthrough in Liquid Biopsy With Over 99% Cancer DNA Purity

VolitionRx (NYSE American: VNRX) announced a breakthrough in liquid biopsy technology, achieving over 99% purity in isolating circulating tumor-derived DNA using its Capture-Seq(TM) platform, overcoming a longstanding challenge of distinguishing cancer DNA from healthy cell-free DNA in blood samples. The company reported strong early validation results, including no false positives and successful detection across initial study cohorts, supporting the potential of the technology as a novel biomarker approach. The company said the advancement could support applications in multi-cancer early detection and minimal residual disease monitoring, representing a combined total addressable market of approximately $36 billion. Volition added that it is…

Continue Reading

TuesdayMar 17, 2026 11:57 am

NetworkNewsBreaks – Cyngn Inc. (NASDAQ: CYN) Closes $9.65 Million Registered Direct Offering

Cyngn (NASDAQ: CYN) announced the closing of its previously announced registered direct offering, raising approximately $9.65 million in gross proceeds through the sale of 5,000,000 shares of common stock and pre-funded warrants at $1.93 per share, with the majority of the offering purchased by a single institutional investor. The transaction was priced at the market under Nasdaq rules and closed on March 17, 2026, with proceeds expected to support general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent.  To view the full press release, visit https://nnw.fm/ihUj4 About Cyngn  Cyngn develops and deploys autonomous vehicle technology for industrial organizations like manufacturers and logistics companies. The Company addresses significant…

Continue Reading

TuesdayMar 17, 2026 11:40 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On Bioequivalence For Ketamine Product 

NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a letter from the FDA’s Bioequivalence Program stating no bioequivalence deficiencies were identified at this time in its Abbreviated New Drug Application, with a preliminary determination ahead of anticipated approval in Summer 2026. The company highlighted its preservative-free ketamine formulation, which excludes benzethonium chloride, as a potential advancement in safety and stability, while continuing to pursue regulatory pathways for broader therapeutic use. To view the full press release, visit https://nnw.fm/DfwXx About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc. (www.nrxpharma.com), is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic…

Continue Reading

TuesdayMar 17, 2026 11:35 am

NetworkNewsBreaks – REalloys Inc. (NASDAQ: ALOY) Highlighted As Rare Earth Supply Chain Rebuild Gains Urgency

REalloys (NASDAQ: ALOY) was featured in a market commentary published by OilPrice.com and authored by Michael Kern, which examines how China’s control over rare earth metallization continues to underpin critical global technology supply chains supporting companies including Micron Technology Inc. (NASDAQ: MU), Advanced Micro Devices Inc. (NASDAQ: AMD), International Business Machines Corporation (NYSE: IBM), Oracle Corporation (NYSE: ORCL) and Meta Platforms Inc. (NASDAQ: META). The report highlights REalloys’ efforts to reestablish North American metallization capacity through its Ohio operations, addressing a key gap in converting rare earth oxides into high-purity metals and alloys essential for permanent magnet production. The commentary…

Continue Reading

TuesdayMar 17, 2026 10:10 am

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Featured In MiningNewsWire Editorial On Gold Market Trends

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced its inclusion in a MiningNewsWire editorial highlighting how rising gold prices are reshaping new mine development, noting the company’s progress in Québec’s Abitibi Gold Belt through a favorable Preliminary Economic Assessment for the Swanson Gold Project, supportive drilling results and ongoing refurbishment of the Beacon Gold Mill as it advances toward potential production. To view the full press release, visit https://nnw.fm/QevBj About LaFleur Minerals Inc. LaFleur Minerals is focused on the development of district-scale gold projects…

Continue Reading

TuesdayMar 17, 2026 10:06 am

NetworkNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Completes Participation In U.S. Army TiC 2.0 Autonomous Breach Event 

Safe Pro Group (NASDAQ: SPAI) announced it has completed participation in the U.S. Army Transforming in Contact (TiC) 2.0 Autonomous Breach event, where its patented AI tools were deployed in real-world operational environments by soldiers and command personnel during a two-week exercise at Fort Hood, Texas. The company’s SPOTD platform and NODE system were used to identify threats, generate terrain models, and support mission planning, with the performance driving expanded pipeline opportunities and new capability requests from Army personnel. To view the full press release, visit https://nnw.fm/1EH4p About Safe Pro Group Inc. Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company delivering AI-enabled security…

Continue Reading

TuesdayMar 17, 2026 9:36 am

NetworkNewsBreaks – Renewal Fuels, Inc. (OTC: RNWF) Provides Legal And Regulatory Update

Renewal Fuels (OTC: RNWF) reported that the Delaware Court of Chancery denied a plaintiff’s motions related to its Series 2020 Super Voting Preferred Share, finding no colorable ownership claim or risk of irreparable harm, while the company plans to file a motion to dismiss within 30 days and continues separate litigation in Washington State regarding the return of improperly issued shares. The company also withdrew and refiled its Form 10 under Section 12(g) after addressing clerical and classification matters, noting that the updates did not impact previously reported financial results. To view the full press release, visit: https://nnw.fm/qGYt1 About Renewal Fuels, Inc. and American Fusion Renewal…

Continue Reading

TuesdayMar 17, 2026 9:35 am

NetworkNewsBreaks – YY Group Holding Limited (NASDAQ: YYGH) Launches Robotics Pilot Program In Las Vegas

YY Group Holding (NASDAQ: YYGH) announced the launch of a robotics pilot program in Las Vegas, Nevada, where it will test hospitality and security robots in collaboration with a local robotics company over an expected one-year period. The program will evaluate real-world applications across hotel operations, guest services, and security monitoring, with the company aiming to assess improvements in efficiency and service delivery and potentially expand deployments across hospitality and commercial properties if successful. To view the full press release, visit https://nnw.fm/KMuDz About YY Group Holding Limited YY Group Holding Limited (Nasdaq: YYGH) is a Singapore-headquartered, technology-enabled platform providing flexible,…

Continue Reading

TuesdayMar 17, 2026 9:00 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Schedules Q4 And Full-Year 2025 Financial Results Release

Datavault AI (NASDAQ: DVLT) announced it will report financial results for the fourth quarter and full year 2025 prior to market open on March 19, 2026, followed by a conference call and live webcast at 8:30 a.m. ET the same day. CEO Nathaniel Bradley and CFO Brett Moyer will host the presentation, with dial-in access available for U.S. and international participants. To view the full press release, visit https://nnw.fm/ivEpb About Datavault AI Datavault AI(TM) (Nasdaq:DVLT) leads AI-driven data experiences, valuation, and monetization in the Web 3.0 environment. The Company's cloud-based platform delivers comprehensive solutions through its collaborative Acoustic Science and…

Continue Reading

TuesdayMar 17, 2026 9:00 am

NetworkNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances GelrinC(R) Manufacturing With New Solvent-Free Production Process

Regentis Biomaterials (NYSE American: RGNT) announced the development of a new proprietary solvent-free manufacturing process for GelrinC(R), its off-the-shelf hydrogel implant for treating focal articular knee cartilage injuries, that more than quadruples production yield per batch. The company said the new process is designed to improve production economics and gross margins ahead of GelrinC(R)’s planned European commercial launch later this year, while patent filings for the manufacturing innovation have already been granted in India, China and Israel, with U.S. approval pending. To view the full press release, visit https://nnw.fm/HYySr About Regentis Biomaterials Regentis Biomaterials Ltd is a regenerative medicine company…

Continue Reading